论文信息 - Benefit of rituximab combined to ACVBP (R-ACVBP) over ACVBP in 209 poor- risk BDLC NHL patients treated with up-front consolidative autotransplantation: A GELA phase II trial (LNH 2003-3). - 字舞流文

Benefit of rituximab combined to ACVBP (R-ACVBP) over ACVBP in 209 poor- risk BDLC NHL patients treated with up-front consolidative autotransplantation: A GELA phase II trial (LNH 2003-3).

B. Coiffier | O. Casasnovas | P. Feugier | H. Tilly | C. Gisselbrecht | C. Fermé | N. Mounier | C. Haioun | O. Fitoussi | J. Brière | K. Belhadj